Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
JAMA Network Open2021Vol. 4(4), pp. e216139–e216139
Citations Over TimeTop 1% of 2021 papers
Lauren A. Eberly, Lin Yang, Nwamaka D. Eneanya, Utibe R. Essien, Howard Julien, Ashwin S. Nathan, Sameed Ahmed M. Khatana, Elias J. Dayoub, Alexander C. Fanaroff, Jay Giri, Peter W. Groeneveld, Srinath Adusumalli
Abstract
In this cohort study, use of an SGLT2 inhibitor treatment increased among patients with type 2 diabetes from 2015 to 2019 but remained low, particularly among patients with HFrEF, CKD, and ASCVD. Black and female patients and patients with low socioeconomic status were less likely to receive an SGLT2 inhibitor, suggesting that interventions to ensure more equitable use are essential to prevent worsening of well-documented disparities in cardiovascular and kidney outcomes in the US.
Related Papers
- → How Socioeconomic Status Influences Fathers’ Involvement with their Children and the Cycle it Produces(2018)2 cited
- → Race and socioeconomic status as confounding variables in the accurate diagnosis of alcoholism(1982)12 cited
- → Socioeconomic status and mental health(2022)1 cited
- Socioeconomic Status and Health: Dimensions and Mechanisms(2008)
- [Physical activity and leisure time in children. I: Relation to socioeconomic status].(1997)